(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SERONO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

SERONO

ST13

US500000075129106

Class

5

Filing

75129106

Registration

2059423

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

05/07/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

07/02/1996

Registration date

05/06/1997

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/01/2017

Last transaction

05/07/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1976-06-00

First use in commerce

1976-06-00

Drawing code

4

Owner type

99

Owner location

DARMSTADT, DE

Examiner

CASE, LEIGH CAROLINE

Law office

L50

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

MERCK KGAA
ARES TRADING S.A.
ARES TRADING S.A.

Representatives

William C. Wright Epstein Drangel LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

house mark for a full line of pharmaceutical preparations for use in the treatment of infertility and/or ovulation inductionimmunology -- oncologypediatrics and endocrinologyauto immune diseasesgrowth and metabolismdiseases of the central nervous systemcancercardiovascular and circulatory diseasesviral diseasesinflammatory and hematological disorderscalcium disordersantiviral preparations for opthalmic use

Publications

History of USPTO decisions and trademark events.

29 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/06/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/01/2017

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

12/01/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/01/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/01/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

11/03/2017

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/06/2016

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

10/09/2013

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/08/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/08/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/12/2008

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/12/2008

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/22/2007

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/22/2007

PLGL

ASSIGNED TO PARALEGAL

03/19/2007

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/25/2007

MAIL

PAPER RECEIVED

01/25/2007

CFIT

CASE FILE IN TICRS

01/05/2007

A7OK

AMENDMENT UNDER SECTION 7 - PROCESSED

10/26/2006

PLGL

ASSIGNED TO PARALEGAL

07/25/2006

AMD7

SEC 7 REQUEST FILED

06/16/2006

MAIL

PAPER RECEIVED

06/16/2006

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/19/2003

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

09/26/2003

R.PR

REGISTERED-PRINCIPAL REGISTER

05/06/1997

PUBO

PUBLISHED FOR OPPOSITION

02/11/1997

NPUB

NOTICE OF PUBLICATION

01/10/1997

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/06/1996

DOCK

ASSIGNED TO EXAMINER

12/02/1996

Continuous trademark protection

Get notified about every new filing that threatens SERONO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.